Compugen (CGEN) Leases (2019 - 2025)
Compugen recorded quarterly Leases of $2.5 million in Q4 2025, down 11.33% quarter-over-quarter from $2.8 million in Q4 2024, and down 11.33% year-over-year from $2.8 million in Q4 2024.
Compugen's Leases history runs 6 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- In Q4 2025, Leases fell 11.33% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (down 11.33% YoY), while the FY2025 annual figure was $2.5 million, down 11.33% from the prior year.
- Leases came in at $2.5 million for Q4 2025 at Compugen, down from $2.8 million in the prior quarter.
- In the past five years, Leases ranged from a high of $2.8 million in Q4 2024 to a low of $1.3 million in Q4 2023.
- A 5-year average of $2.2 million and a median of $2.2 million in 2021 frame the typical range for Leases.
- Across the five-year window, Leases fell 27.22% in 2023 and jumped 113.92% in 2024, its largest moves.
- Compugen's Leases stood at $2.2 million in 2021, then decreased by 18.74% to $1.8 million in 2022, then dropped by 27.22% to $1.3 million in 2023, then surged by 113.92% to $2.8 million in 2024, then declined by 11.33% to $2.5 million in 2025.
- According to Business Quant data, Leases over the past three periods registered $2.5 million, $2.8 million, and $1.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 2.25 Mn |
| Dec 31, 2020 | 2.77 Mn |
| Mar 31, 2019 | 4.76 Mn |